BCG Tuberculosis Vaccine Market

BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.

BCG Tuberculosis Vaccine Market contains market size and forecasts of BCG Tuberculosis (TB) Vaccine in global, including the following market information:

• Global BCG Tuberculosis (TB) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global BCG Tuberculosis (TB) Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five BCG Tuberculosis (TB) Vaccine companies in 2021 (%)

The global BCG Tuberculosis (TB) Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immune BCG Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of BCG Tuberculosis (TB) Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Wesurveyed the BCG Tuberculosis (TB) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global BCG Tuberculosis (TB) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global BCG Tuberculosis (TB) Vaccine Market Segment Percentages, by Type, 2021 (%)

• Immune BCG
• Therapy BCG

Global BCG Tuberculosis (TB) Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global BCG Tuberculosis (TB) Vaccine Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global BCG Tuberculosis (TB) Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global BCG Tuberculosis (TB) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies BCG Tuberculosis (TB) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies BCG Tuberculosis (TB) Vaccine revenues share in global market, 2021 (%)
• Key companies BCG Tuberculosis (TB) Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies BCG Tuberculosis (TB) Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Sanofi Pasteur
• Japan BCG Lab
• China National Biotec
• Serum Institute of India
• Intervax
• GSBPL